However, another study conducted by Wakabayashi et al. indicated that CD4+ T cells in the cancer stroma, but not CD8+ T cells in cancer cell nests, are associated with a favorable prognosis in NSCLC [40]. This evidence concerns the gene CD4 and cancer.